Discovery Chemistry

Enzyme activity assays (standardised QC panels)  Heparin potency and purity testing  Low Molecular Weight Heparin (LMWH) assays, including Enoxaparin  Full

Routine QC testing and Certificate of Analysis (CoA) generation  Validation of stability-indicating analytical methods  Provides reliable release data for commercial

Enantiomeric purity assessment and resolution  Chiral LC method development and preparative purification  Supports enantioselective development programs with precision analytical techniques

Analytical method development and validation (ICH Q2)  HPLC, UPLC, GC, GC-MS, LC-MS/MS, and CE techniques  Impurity profiling, quantitation, and structural

Container–closure compatibility  Extractables and leachables studies for parenteral products  ICH-compliant accelerated and long-term stability studies  Forced degradation studies for stability-indicating methods  Assures

Salt and polymorph screening  Particle engineering and solid form selection  Pre-formulation and formulation development for oral (IR/MR), parenteral (sterile/lyophilised), inhalation, topical,

API synthesis, optimisation, and process development  Pilot and GMP-scale API manufacturing  Technology transfer to manufacturing facilities  Ensures reproducible, high-yield production of APIs